Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Part of paid clinical trials in Indianapolis, Indiana.
- Sponsor
- Indiana University
- Study ID
- NCT07761910
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Cardiotoxicity
- Locally Advanced Non-Small Cell Lung Cancer
- Non Small Cell Lung Cancer
- Radiation Therapy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- PET/CT 18F-Flurpiridaz Rest/Stress Test — DIAGNOSTIC_TESTA two-phase, rest and regadenoson stress evaluated by 18F-Flurpiridaz PET/CT before and 3 months after SOC radiation treatment.
- Coronary CT Angiography (CCTA) — DEVICECoronary computed tomographic angiography (CCTA) scan is a highly accurate noninvasive technique for detection of coronary artery plaque.
- 18F-Flurpiridaz — DRUGA two-phase, rest and regadenoson stress evaluated by 18F-Flurpiridaz PET/CT before and 3 months after SOC radiation treatment
Study Details
Prospective clinical study designed to evaluate damage to the heart after receiving standard of care chemotherapy and radiation therapy for locally advanced Non-Small Cell Lung Cancer (NSCLC).
Key Dates
- First listed
- Aug 12, 2026
- Start date
- Sep 30, 2026
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: PET/CT 18F-Flurpiridaz Rest/Stress TestA two-phase, rest and regadenoson stress evaluated by 18F-Flurpiridaz PET/CT before and 3 months after SOC radiation treatment.
Primary Outcome Measure
Change of MBF (myocardial blood flow) [ Time Frame: Pre-radiotherapy and 3 months post-radiotherapy ]
Central Contacts
- Jessica Anders1 317-278-2722
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Indiana University Melvin and Bren Simon Comprehensive Cancer Center | Indianapolis | Indiana | 46202 | Jordan Holmes, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Indianapolis, IN
By condition
By specialty
Related Studies
- S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPHASE3 · Recruiting · SWOG Cancer Research Network · Duarte, California
- A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)PHASE3 · Recruiting · AbbVie · Duarte, California
- ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 InhibitorsPHASE3 · Recruiting · OncoC4, Inc. · Dothan, Alabama
- A Phase 1 of CTX-8371 in Patients With Advanced MalignanciesPHASE1 · Recruiting · Compass Therapeutics · Orlando, Florida